摘要
目的：观察分析胰腺癌肝转移的介入治疗效果。方法选择我院在2011年9月～2014年2月收治的50例胰腺癌肝转移患者，采取随机法把患者划分为治疗组和对照组，两组患者例数均为25例，两组患者均予以放疗，基于此，治疗组施予介入治疗，包含肝动脉化疗栓塞和胰腺动脉灌注化疗，比较分析两组患者治疗效果和平均生存时间。结果治疗组治疗总有效率（44.0%）高于对照组，且患者平均生存时间也长于对照组，组间数据比较差异有统计学意义，P＜0.05。结论采用介入治疗胰腺癌肝转移患者，可使患者肿瘤缩小，延缓病情发展和延长患者生存时间。
Objective To observe the effect of interventional therapy for liver metastasis of pancreatic cancer.Methods 50 cases of pancreatic cancer with liver metastases were enroled in our hospital from September 2011 to February 2014,the patients were divided into treatment group and control group, two groups of patients were 25 cases,two groups of patients were treated with radiotherapy,based on this,the treatment group giving interventional therapy,transcatheter arterial chemoembolization（TACE）and pancreatic artery perfusion chemotherapy,a comparative analysis of the therapeutic effect of two groups of patients and the mean survival time.ResultsIn treatment group the total efficiency（44.0%）was significantly higher than that of the control group and patients with an average survival time was longer than that of the control group,the data was compared between the two groups had significant difference and was statisticaly significant,P〈 0.05.Conclusion Interventional treatment of liver metastasis in patients with pancreatic cancer,can make the tumor shrink,delay the development of the disease and prolong the survival time of patients,the effect is good.
出处
《中国卫生标准管理》
2015年第20期60-61,共2页
China Health Standard Management
关键词
介入治疗
胰腺癌
肝转移
生存时间
Interventional therapy
Pancreatic cancer
Liver metastasis
Survival time
